Luciferase assays revealed that STAT3 is a direct target of miR-124a, and treatment of HTLV-1/ATLL cell lines with a STAT3 inhibitor, S3I-201, led to decreased proliferation. The gene discussed is STAT3; the disease is adult T-cell leukemia/lymphoma.